CARDIOLITE

LOE Approaching

tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate

NDAINJECTIONINJECTABLE
Approved
Dec 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3

Mechanism of Action

Tc99m Sestamibi is a cationic Tc99m complex which has been found to accumulate in viable myocardial tissue in a manner analogous to that of thallous chloride Tl-201. Scintigraphic images obtained in humans after the intravenous administration of the drug have been comparable to those obtained with…

Indications (1)

Clinical Trials (3)

NCT00162032Phase 3Completed

A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease

Started Aug 2005
445 enrolled
Kawasaki Disease
NCT00162045Phase 1/2Completed

A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects

Started Jan 2005
79 enrolled
Kawasaki Disease
NCT00162331Phase 4Completed

CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI

Started Jan 2005
74 enrolled
Myocardial Infarction